Expansion Details⁤ and Timeline

Merck, a leading science and technology company, is considerably expanding it’s Life Science operations in Cork, Ireland, with a total investment of €440 million across its facilities in Blarney ⁤and carrigtwohill. A key component of this investment is a new, state-of-the-art facility in‍ Blarney,‍ designed to operate with neutral operations powered entirely by renewable electricity. Merck stated this ⁤expansion marks a significant step towards its ⁤goal of achieving climate neutrality by 2040. [Merck Press Release](https://www.merck.com/news/press-releases/merck-invests-440-million-in-cork-ireland-to-expand-biomanufacturing-capacity)

The new Blarney facility is expected to commence production in the fourth quarter of 2025.It will focus‍ on manufacturing filtration devices crucial for aseptic processing, tangential-flow filtration,‍ and virus ‍filtration – technologies⁣ vital for ensuring the safety, sterility, and efficacy⁣ of medicines.

This expansion is projected to ⁢create over 200 new jobs in Cork by 2028, bolstering Ireland’s position as a prominent global hub for⁣ biopharmaceutical manufacturing and innovation.

Strategic Importance of the Cork Location

Jean-Charles Wirth,⁣ CEO of Merck Life Science, emphasized ⁢Ireland’s role as ‍a leading hub for biopharmaceutical manufacturing and innovation in both Europe and globally. he highlighted ⁢that the Cork ⁢expansion reinforces Merck’s “in-region-for-region” manufacturing and supply model. This strategy aims to ‍shorten lead times, mitigate cross-border risks, and provide customers ⁢with reliable access to critical filtration technologies needed for developing life-changing therapies.

Mark Dunphy, Managing Director and Head of⁢ Cork operations at Merck Life Science, Ireland, underscored the ⁢company’s long-term commitment to Ireland and the extraordinary ⁣talent pool available in Cork. He stated the investment will strengthen their ability⁢ to deliver cutting-edge technologies supporting the manufacture of breakthrough therapies worldwide.

Government Support and Regional Impact

The investment has received support from the Irish government. Minister of State Jerry Buttimer, representing ⁢the Department ‍of Rural and ⁣Community Advancement and the Gaeltacht, and the Department of Transport, affirmed ⁣that Merck’s⁣ significant investment further solidifies Ireland’s reputation‍ as a global center for ‍biopharmaceutical ⁣manufacturing and innovation. He added that⁤ the commitment demonstrates the ⁣attractiveness of the region for leading life sciences companies.

Ireland has actively sought to attract foreign direct investment in ‍the pharmaceutical sector, offering a skilled workforce, a favorable tax ⁤surroundings, and a strong regulatory framework. According to IDA Ireland, the biopharmaceutical sector is one of the ‍fastest-growing in the country, ⁣employing over 30,000 people. ‍ [IDA Ireland – Biopharma](https://www.idaireland.com/sectors/biopharma)

About Merck Life Science

Merck Life Science is the life science business ⁤of Merck KGaA, darmstadt, Germany (branded as EMD in ⁣the US and Canada). The ‍company⁤ provides scientists and engineers with ⁣a portfolio of lab materials, technologies and services. Merck KGaA reported €22.4 ⁣billion in sales in 2022.[Merck KGaA Annual report 2022](https://www.merckgroup.com/content/dam/pr/annual-report/2022/en/merck-annual-report-2022-en.pdf)